ABEVMY 25 mg/mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 4 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400955081432 -
CIP7
5508143 -
CIS
67397826 -
Registration number
EU/1/20/1515
What the source publishes
- Holder
- BIOSIMILAR COLLABORATIONS IRELAND (IRLANDE)
- Active ingredients
- BÉVACIZUMAB
- Form
- solution à diluer pour perfusion
- Package
- 1 flacon(s) en verre de 4 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- réservé à l'usage HOSPITALIER ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2021-04-21
- Prescription
- Prescription or restricted
Names this record is found by
- ABEVMY 25 mg/mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 4 ml
- ABEVMY 25 mg/mL, solution à diluer pour perfusion
- BÉVACIZUMAB
Complete source data
{
"cis": "67397826",
"cip7": "5508143",
"form": "solution à diluer pour perfusion",
"name": "ABEVMY 25 mg/mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 4 ml",
"cip13": "3400955081432",
"holder": "BIOSIMILAR COLLABORATIONS IRELAND (IRLANDE)",
"routes": [
"intraveineuse"
],
"holders": [
"BIOSIMILAR COLLABORATIONS IRELAND (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2021-04-21",
"compositions": [
{
"name": "BÉVACIZUMAB",
"nature": "SA",
"strength": "25 mg",
"linkageNumber": "1",
"substanceCode": "70202",
"dosageReference": "1 mL de solution",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "réservé à l'usage HOSPITALIER ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ABEVMY 25 mg/mL, solution à diluer pour perfusion",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 4 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2023-03-15",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"BÉVACIZUMAB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"réservé à l'usage HOSPITALIER",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/20/1515",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400955081432"